The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Hims & Hers Health Inc (NYSE: HIMS) closed the day trading at $51.94 up 1.74% from the previous closing price of $51.05. In other words, the price has increased by $1.74 from its previous closing price. On the day, 23.1 million shares were traded. HIMS stock price reached its highest trading level at $52.7 during the session, while it also had its lowest trading level at $50.43.
Ratios:
For a better understanding of HIMS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 100.79. For the most recent quarter (mrq), Quick Ratio is recorded 4.46 and its Current Ratio is at 4.98. In the meantime, Its Debt-to-Equity ratio is 1.86 whereas as Long-Term Debt/Eq ratio is at 1.85.
On June 04, 2025, Needham reiterated its Buy rating and also lowered its target price recommendation from $61 to $65.
TD Cowen Downgraded its Buy to Hold on April 29, 2025, while the target price for the stock was maintained at $30.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 06 ’25 when Carroll Patrick Harrison sold 60,000 shares for $53.58 per share. The transaction valued at 3,214,878 led to the insider holds 169,940 shares of the business.
Carroll Patrick Harrison bought 60,000 shares of HIMS for $3,214,881 on Aug 06 ’25. On Jul 31 ’25, another insider, Chi Michael, who serves as the Chief Commercial Officer of the company, sold 26,350 shares for $67.00 each. As a result, the insider received 1,765,450 and left with 278,654 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 11739478016 and an Enterprise Value of 11639230464. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 65.01, and their Forward P/E ratio for the next fiscal year is 62.20. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.27. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.83 while its Price-to-Book (P/B) ratio in mrq is 20.84. Its current Enterprise Value per Revenue stands at 5.78 whereas that against EBITDA is 72.675.
Stock Price History:
The Beta on a monthly basis for HIMS is 2.19, which has changed by 2.2523482 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $13.47. The 50-Day Moving Average of the stock is -3.22%, while the 200-Day Moving Average is calculated to be 32.46%.
Shares Statistics:
Over the past 3-months, HIMS traded about 43.80M shares per day on average, while over the past 10 days, HIMS traded about 42341100 shares per day. A total of 217.38M shares are outstanding, with a floating share count of 201.87M. Insiders hold about 10.69% of the company’s shares, while institutions hold 69.26% stake in the company. Shares short for HIMS as of 1752537600 were 65295727 with a Short Ratio of 1.49, compared to 1749772800 on 61690896. Therefore, it implies a Short% of Shares Outstanding of 65295727 and a Short% of Float of 36.230000000000004.
Earnings Estimates
The current market rating for Hims & Hers Health Inc (HIMS) reflects the collective analysis of 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.26, with high estimates of $0.31 and low estimates of $0.17.
Analysts are recommending an EPS of between $1.24 and $0.78 for the fiscal current year, implying an average EPS of $1.07. EPS for the following year is $1.38, with 5.0 analysts recommending between $1.77 and $0.99.
Revenue Estimates
10 analysts predict $579.55M in revenue for the current quarter. It ranges from a high estimate of $590.87M to a low estimate of $567.56M. As of the current estimate, Hims & Hers Health Inc’s year-ago sales were $401.56MFor the next quarter, 10 analysts are estimating revenue of $635.17M. There is a high estimate of $685.04M for the next quarter, whereas the lowest estimate is $615.54M.
A total of 12 analysts have provided revenue estimates for HIMS’s current fiscal year. The highest revenue estimate was $2.41B, while the lowest revenue estimate was $2.32B, resulting in an average revenue estimate of $2.35B. In the same quarter a year ago, actual revenue was $1.48BBased on 11 analysts’ estimates, the company’s revenue will be $2.82B in the next fiscal year. The high estimate is $3B and the low estimate is $2.66B.
